Dr. Mark Horowitz, MBBS PhD is a training psychiatrist and Clinical Research Fellow in Psychiatry North East London NHS Foundation Trust (NELFT) and an Honorary Clinical Research Fellow at UCL. He runs the Psychotropic drug Deprescribing Clinic in North East London NHS Foundation Trust. Mark completed a PhD in the neurobiology of depression and the action of antidepressants at the Institute of Psychiatry, Psychology and Neuroscience at King’s College London.
Dr. Horowitz is an Associate Editor of the journal Therapeutic Advances in Psychopharmacology. He co-authored the recent Royal College of Psychiatry guidance on ‘Stopping Antidepressants’, and his work has informed the recent NICE guidelines on safe tapering of psychiatric medications. He has written several papers about safe approaches to tapering psychiatric medications including publications in The Lancet Psychiatry, JAMA Psychiatry and Schizophrenia Bulletin.
Chemical imbalance – psychiatry as a pharma marketing tool
